NEUP

NASDAQStock

Neuphoria Therapeutics Inc.

$4.61-0.13 (-2.64%)

52-Week Range

$3.72

$20.00

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.50

Volume

73.7K

Avg Volume

63.8K

Performance

+17.96%

+23.50%

-60.81%

YTD

+23.82%

-2.27%

-28.66%

Price Chart

ETF Exposure

NEUP is held by 3 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
PSIL	AdvisorShares Psychedelics ETF	3.08%	148,627	$638K	$20.4M	1.84%
VTI	Vanguard Total Stock Market ETF	0.00%	23,961	$96K	$2.10T	0.03%
VXF	Vanguard Extended Market ETF	0.00%	11,072	$45K	$84.10B	0.05%

About NEUP ETF Exposure

Neuphoria Therapeutics Inc. (NEUP) is held by 3 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $4.61. Investors can gain exposure to NEUP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold NEUP, sorted by portfolio weight.